When it comes to the brain, levels of molecules involved in neuronal signaling must be “just right,” or things can go terribly wrong.

Huda Zoghbi, M.D., recipient of the 2015 Vanderbilt Prize in Biomedical Science, will deliver her Vanderbilt Prize Lecture on Thursday, April 21.

Researchers at Vanderbilt University Medical Center have “turned back the clock” in a mouse model of metaplasia — precancerous stomach lesions — raising hopes that gastric cancer, a worldwide scourge that’s rising in the United States, can be prevented.

The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease’s slow progression.

A microRNA — a small piece of RNA involved in regulating gene expression — functions as an oncogene to drive the development of lung cancer, Vanderbilt University investigators have discovered.

There may be a “silver bullet” for Ebola, a family of hemorrhagic viruses, one of which has killed more than 11,000 people in West Africa in the past two years.

Certain protein factors have been identified as attractive targets for treating diabetic retinopathy, a major cause of blindness in adults.